Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dentin Hypersensitivity Suppression Effect of DH-1N Mouthwash
jRCT1060230066Not yet recruiting
- Sponsor
- Earth Corporation
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of Mondamine DH-1N in Dentinal hypersensitivity (DH), sponsored by Earth Corporation. Primary endpoint: Change in dentin hypersensitivity pain (abrasion, cold air, cold water) on NRS. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
Mondamine DH-1N
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on jRCT1060230066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1060230066.